CompaniesFluoroPharma

FluoroPharma

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

4

As Collaborator

0

Total Enrollment

107

By Phase

PHASE2: 2PHASE1: 2

By Status

COMPLETED: 3UNKNOWN: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Today
NCT00733460
NCT01826773
Hover over trial bars to see details

Recent Trials

NCT02252783Lead Sponsor
BFPET for Regional Myocardial Perfusion Imaging
PHASE2Unknown
40 participants
Started: Oct 1, 2018 · Completed: Sep 30, 2019
NCT01826773Lead Sponsor
CardioPET as PET Imaging Agent to Assess Myocardial Perfusion and Fatty Acid Uptake in Known or Suspected CAD Subjects
PHASE2Completed
34 participants
Started: Mar 31, 2013 · Completed: Sep 30, 2016
NCT00733460Lead Sponsor
A Phase I Study to Evaluate BFPET as a Potential Myocardial Perfusion Imaging(MPI) Agent for PET
PHASE1Completed
12 participants
Started: Mar 31, 2008 · Completed: Jan 31, 2012
NCT00413647Lead Sponsor
A Phase I Study in Healthy Volunteers to Evaluate the Safety of CardioPET™ in Detection of Coronary Artery Disease
PHASE1Completed
21 participants
Started: Sep 30, 2006 · Completed: Feb 29, 2008